These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10768459)

  • 1. Meningococcal vaccine and herd immunity.
    Ozsoylu S
    Lancet; 2000 Mar; 355(9208):1015; author reply 1016. PubMed ID: 10768459
    [No Abstract]   [Full Text] [Related]  

  • 2. Meningococcal vaccine and herd immunity.
    Marks P; Singleton C; Fey R; Neal K
    Lancet; 2000 Mar; 355(9208):1015; author reply 1016. PubMed ID: 10768460
    [No Abstract]   [Full Text] [Related]  

  • 3. Meningococcal vaccine and herd immunity.
    Gikas A; Pediaditis J; Tselentis Y
    Lancet; 2000 Mar; 355(9208):1016. PubMed ID: 10768461
    [No Abstract]   [Full Text] [Related]  

  • 4. Meningococcal vaccine and herd immunity.
    Sbyrakis S; Galanakis E
    Lancet; 1999 Nov; 354(9191):1733. PubMed ID: 10568605
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of BC meningococcal vaccine in Brazil.
    Nishioka S
    Int J Epidemiol; 1996 Oct; 25(5):1102-3. PubMed ID: 8921501
    [No Abstract]   [Full Text] [Related]  

  • 6. "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa.
    Robbins JB; Towne DW; Gotschlich EC; Schneerson R
    Lancet; 1997 Sep; 350(9081):880-2. PubMed ID: 9310615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
    Wu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
    [No Abstract]   [Full Text] [Related]  

  • 8. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial of a serogroup A meningococcus polysaccharide vaccine in Nigeria.
    Sanborn WR; Bencić Z; Cvjetanović B; Gotschlich EC; Pollock TM; Sippel JE
    Prog Immunobiol Stand; 1971; 5():497-505. PubMed ID: 4633977
    [No Abstract]   [Full Text] [Related]  

  • 10. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
    Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defences against meningococcal infections.
    Lancet; 1985 Oct; 2(8461):929-30. PubMed ID: 2865427
    [No Abstract]   [Full Text] [Related]  

  • 12. [Meningococcal meningitis: preliminary epidemiological results on the introduction of a prophylactic vaccine].
    Galli MG
    G Batteriol Virol Immunol; 1982; 75(7-12):251-4. PubMed ID: 7188258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a meningococcal vaccine.
    Poolman JT
    Infect Agents Dis; 1995 Mar; 4(1):13-28. PubMed ID: 7728353
    [No Abstract]   [Full Text] [Related]  

  • 14. [Observation on the epidemiologic efficacy for 9 years on epidemic meningococcal polysaccharide vaccine of group A by district immunization method].
    Ma Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Apr; 12(2):69-71. PubMed ID: 2065343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of meningococcal disease in west Africa.
    Lewis R; Varaine F; Belanger F; Nathan N; Diarra L
    Lancet; 2000 Apr; 355(9210):1185-6. PubMed ID: 10791404
    [No Abstract]   [Full Text] [Related]  

  • 16. Committee to Advise on Tropical Medicine and Travel (CATMAT). Statement on meningococcal vaccination for travellers.
    Can Commun Dis Rep; 1995 Feb; 21(4):25-9. PubMed ID: 7735191
    [No Abstract]   [Full Text] [Related]  

  • 17. A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria.
    Wahdan MH; Sallam SA; Hassan MN; Abdel Gawad A; Rakha AS; Sippel JE; Hablas R; Sanborn WR; Kassem NM; Riad SM; Cvjetanović B
    Bull World Health Organ; 1977; 55(6):645-51. PubMed ID: 413639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
    Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
    Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
    Krizova P; Musilek M
    Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in immunisation against bacterial infection in children.
    Trück J; Pollard AJ
    Early Hum Dev; 2010 Nov; 86(11):695-701. PubMed ID: 20851537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.